DETECTION OF MALARIAL SPOROZOITES BY THE ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)

Detection of malarial sporozoites by a double antibody sandwich enzyme linked immunosorbent assay (ELISA) is described. This investigation utilized the Anopheles stephensi-Plasmodium berghei malaria model for the generation of sporozoites. Anti-sporozoite antibody was obtained from the sera of rats which had been bitten by An. stephensi with salivary gland sporozoites. Mosquitoes were irradiated prior to feeding on the rats to render the sporozoites non-viable.^ The assay employed microtiter plates coated with their rat anti-sporozoite antiserum or rat anti-sporozoite IgG. Intact and sonicated sporozoites were used as antigens. Initially, sporozoites were detected by an ELISA using staphylococcal protein A conjugated with alkaline phosphatase. Sporozoites were also detected using alkaline phosphatase or horseradish peroxidase conjugated to anti-sporozoite IgG. Best results were obtained using the alkaline phosphatase conjugate.^ This investigation included the titration of antigen, coating antibody and labelled antibody as well as studies of various incubation times. A radioimmunoassay (RIA) was also developed and compared with the ELISA for detecting sporozoites. Finally, the detection of a single infected mosquito in pools of 5 to 10 whole, uninfested ones was studied using both ELISA and RIA.^ Sonicated sporozoites were more readily detected than intact sporozoites. The lower limit of detection was approximately 500 sporozoites per ml. Results using ELISA or RIA were similar. The ability of the ELISA to detect a single infected mosquito in a pool of uninfected ones indicates that this technique has potential use in entomological field studies which aim at determining the vector status of anopheline mosquitoes. The potential of the ELISA for identifying sporozoites of different species of malaria is discussed. ^

PREPARATION AND CHARACTERIZATION OF COVALENTLY LINKED ENZYME-ANTIBODY CONJUGATES AND THEIR USE IN MEASURING MINUTE QUANTITIES OF PROTEIN ANTIGENS

The discovery and characterization of oncofetal proteins have led to significant advances in early cancer diagnosis and therapeutic monitoring of patients undergoing cancer chemotherapy. These tumor-associated antigens are presently measured by sensitive, specific immunoassay techniques based on the detection of minute amounts of labeled antigen or antibody incorporated into immune complexes, which must be isolated from free antigen and antibody.^ Since there are several disadvantages with using radioisotopes, the most common immunolabel, one major objective was to prepare covalently coupled enzyme-antibody conjugates and evaluate their use as a practical alternative to radiolabeled immune reagents. An improved technique for the production of enzyme-antibody conjugates was developed that involves oxidizing the carbohydrate moieties on a glycoprotein enzyme, then introducing antibody in the presence of polyethylene glycol (PEG). Covalent enzyme-antibody conjugates involving alkaline phosphatase and amyloglucosidase were produced and characterized.^ In order to increase the sensitivity of detecting the amyloglucosidase-antibody conjugate, an enzyme cycling assay was developed that measures glucose, the product of maltose cleavage by amyloglucosidase, in the picomole range. The increased sensitivity obtained by combined usage of the amyloglucosidase-antibody conjugate and enzyme cycling assay was then compared to that of conventional enzyme immunoassay (EIA).^ For immune complex isolation, polystyrene tubes and protein A-bearing Staphylococcus aureus were evaluated as solid phase matrices, upon which antibodies can be immobilized. A sandwich-type EIA, using antibody-coated S. aureus, was developed that measures human albumin (HSA) in the nanogram range. The assay, using an alkaline phosphatase-anti-HSA conjugate, was applied to the determination of HSA in human urine and evaluated extensively for its clinical applicability.^ Finally, in view of the clinical significance of alpha-fetoprotein (AFP) as an oncofetal antigen and the difficulty with its purification for use as an immunogen and assay standard, a chemical purification protocol was developed that resulted in a high yield of immunochemically pure AFP. ^

Antibody response to Panton-Valentine Leukocidin, a Staphylococcus aureus virulence factor, in pediatric patients from Texas Children's Hospital in Houston, Texas

Staphylococcus aureus is an important human pathogen of global health significance, whose frequency is increasing and whose persistence and versatility allow it to remain established in communities worldwide. An observed significant increase in infections, particularly in children with no predisposing risk factors or medical conditions, led to an investigation into pediatric humoral immune response to Panton-Valentine Leukocidin (PVL) and to other antigens expressed by S. aureus that represent the important classes of virulence activities. Patients who were diagnosed with staphylococcal infections were enrolled (n=60), and serum samples collected at the time of admission were analyzed using ELISA and Western blot to screen for immune response to the panel of recombinant proteins. The dominant circulating immunoglobulin titers in this pediatric population were primarily IgG, were specific, and were directed against LukF and LukS, while suppression of other important virulence factors in the presence of PVL was suggested. Patients with invasive infections (osteomyelitis, pneumonia or myositis) had higher titers against LukF and LukS compared to patients with non-invasive infections (abscesses, cellulitis or lymphadenitis). In patients with osteomyelitis, antibody responses to LukF and LukS were higher than antibody responses to any other virulence factor examined. This description of immune response to selected virulence factors of S. aureus caused by isolates of the USA300 lineage in children is novel. Antibody titers also correlated with markers of inflammation. The significance of these correlations remains to be understood.^